Article info

Download PDFPDF
The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
  1. Correspondence to Dr Azucena Salas, Center Esther Koplowitz-IDIBAPS-CIBERehd, Rosselló 149-153, Barcelona 08036, Spain; asalas1{at}clinic.ub.es
View Full Text

Citation

Salas A
The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?

Publication history

  • First published January 11, 2013.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.